Skip to main content
Equibles

NORGES BANK

Bank

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1374170 OSLO, Q8
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$10,286,106
+$5,209,334 QoQ
Shares Held
392,300
+124.4% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 271 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. ARQT ranks #39 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,971,681 $1,476,123,103
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,172,808 $731,292,700
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,271,813 $683,883,867
4 BMRN
Biomarin Pharmaceutical Inc
 8,207,954 $469,659,127
5 RVMD
Revolution Medicines, Inc.
 2,157,479 $404,052,667
6 INSM
INSMED Inc
 3,377,641 $360,124,083
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 3,896,536 $317,606,649
8 RPRX
Royalty Pharma plc
 5,336,084 $299,194,229

All Filings in ARQT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,286,106 392,300
2025-12-31 $5,076,772 174,820
2025-06-30 $2,450,976 174,820
2025-03-31 $10,624,564 679,320
2024-12-31 $7,421,806 532,793
2024-09-30 $1,625,826 174,820
2024-06-30 $1,625,826 174,820
2024-03-31 $1,732,466 174,820
2023-12-31 $261,668 81,012
2023-09-30 $430,173 81,012
2023-06-30 $772,044 81,012
2023-03-31 $891,132 81,012
2022-12-31 $1,198,977 81,012
2022-09-30 $1,548,139 81,012
2022-06-30 $1,302,381 61,116
2022-03-31 $1,177,094 61,116
2021-12-31 $5,504,250 265,393
2021-09-30 $1,460,061 61,116
2021-06-30 $1,667,855 61,116
2021-03-31 $1,768,085 61,116
2020-12-31 $593,993 21,116
2020-09-30 $618,698 21,116